PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: targeted drug shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests a new drug, daraxonrasib, against standard treatments in about 500 people with metastatic pancreatic cancer that has already been treated. The drug targets a specific genetic mutation (RAS) found in many pancreatic tumors. Researchers are measuring how lo…
Matched conditions: PDAC
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Can digestive enzymes help fight weight loss in pancreatic cancer?
Disease control OngoingThis study tests whether a pancreatic enzyme replacement called pancrelipase can help maintain or improve body weight in people with metastatic pancreatic cancer. About 17 participants will receive either the enzyme or a placebo, and researchers will measure changes in body mass …
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:15 UTC